Complement-Dependent Cytotoxicity Crossmatch
The complement-dependent cytotoxic crossmatch is an informative test that detects alloantibodies in pre- and post-transplant patients, which may dictate clinical management of transplant patients. While challenging to perform, the cytotoxic crossmatch represents the only assay that provides direct evidence for the presence of potentially pathologic (i.e., cytotoxic) alloantibodies. The cytotoxic crossmatch combines patient (recipient) serum and donor cells. If donor-reactive alloantibodies are present in patient serum, these antibodies can bind donor cells. Antibody-antigen complexes, in turn, can activate the complement cascade, leading to complement-mediated cytotoxicity. Two commonly performed cytotoxic crossmatches, using donor lymphocytes as target cells, are described.
- 疫苗接种的历史
- 间接红血球凝集反应
- 细菌病毒―噬菌体介导的基因转移
- 广州赛诚生物转录调控ChIP标准结果与结论
- 免疫组化的操作步骤
- T-Cell Signaling Abnormalities in Human Systemic Lupus Erythematosus
- Rapid Analysis of Resistant Mutant Genotypes Using Pyrosequencing
- Polyclonal Antibodies
- Pathogenesis of Multiple Sclerosis: What Can We Learn from the Cuprizone Model
- Non-Replicating Recombinant Vaccinia Virus Expressing CD80 to Enhance T-Cell Stimulation